Laurent Peyrin-Biroulet

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease

Federica Furfaro, Ferdinando D’Amico, Alessandra Zilli et al. · Clinical Gastroenterology and Hepatology · 2022 · 40 citations

Medicine, Clinical Sciences, Surgery +13

Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial

Geert D’Haens, Carlos Taxonera, Antonio López–Sanromán et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 37 citations · Full text

Medicine, Pharmacotherapy, Surgery +10

Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study

Bruce E. Sands, Geert D’Haens, David B. Clemow et al. · Inflammatory Bowel Diseases · 2024 · 25 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Janus Kinase Inhibitor-Induced Acne in Inflammatory Bowel Disease: An International, Multicenter, Retrospective Cohort Study

Sailish Honap, María José Temido, Eathar Shakweh et al. · Clinical Gastroenterology and Hepatology · 2025 · 18 citations · Full text

Medicine, Dermatology, Pharmacology +16

A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis

Silvio Danese, Michael E. Rothenberg, Jeremy J. Lim et al. · Clinical Gastroenterology and Hepatology · 2024 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13